Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gtf2i
|
ENSMUSG00000060261.9 | general transcription factor II I |
Gtf2f1
|
ENSMUSG00000002658.9 | general transcription factor IIF, polypeptide 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_57010577_57010739 | Gtf2f1 | 630 | 0.362470 | -0.31 | 1.7e-02 | Click! |
chr17_57010809_57011297 | Gtf2f1 | 235 | 0.613905 | -0.24 | 6.1e-02 | Click! |
chr17_57010372_57010523 | Gtf2f1 | 841 | 0.282239 | -0.24 | 6.4e-02 | Click! |
chr17_57010152_57010303 | Gtf2f1 | 1061 | 0.225720 | -0.24 | 6.7e-02 | Click! |
chr17_57009556_57009915 | Gtf2f1 | 1553 | 0.155519 | -0.22 | 8.9e-02 | Click! |
chr5_134313311_134314643 | Gtf2i | 401 | 0.782924 | -0.29 | 2.5e-02 | Click! |
chr5_134315701_134315852 | Gtf2i | 1016 | 0.426570 | -0.26 | 4.4e-02 | Click! |
chr5_134238437_134238707 | Gtf2i | 2473 | 0.193368 | 0.23 | 7.3e-02 | Click! |
chr5_134238122_134238273 | Gtf2i | 2848 | 0.176623 | 0.22 | 9.1e-02 | Click! |
chr5_134304602_134304753 | Gtf2i | 1932 | 0.233738 | 0.18 | 1.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_126823319_126824529 | 7.18 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr4_101549898_101551379 | 6.43 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
44 |
0.98 |
chr5_116590520_116593206 | 5.84 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr13_109116105_109117683 | 5.71 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
253 |
0.96 |
chr7_44428104_44428935 | 5.56 |
Lrrc4b |
leucine rich repeat containing 4B |
499 |
0.58 |
chr7_3390544_3391386 | 5.49 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
282 |
0.73 |
chr10_86491670_86492273 | 5.43 |
Syn3 |
synapsin III |
74 |
0.96 |
chr9_91366433_91367646 | 5.26 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1229 |
0.26 |
chr5_27048872_27050274 | 5.22 |
Dpp6 |
dipeptidylpeptidase 6 |
180 |
0.97 |
chr8_121730928_121732115 | 5.10 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr16_37938395_37939150 | 5.06 |
Gpr156 |
G protein-coupled receptor 156 |
22276 |
0.15 |
chr3_88208985_88210116 | 5.06 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr17_91092075_91093120 | 5.03 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr1_166255711_166256817 | 4.94 |
Ildr2 |
immunoglobulin-like domain containing receptor 2 |
2071 |
0.3 |
chr3_17793835_17795104 | 4.93 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr6_114282516_114283979 | 4.91 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr1_173365727_173366467 | 4.90 |
Cadm3 |
cell adhesion molecule 3 |
1536 |
0.34 |
chr11_57011668_57012922 | 4.82 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
339 |
0.94 |
chr10_6788358_6789268 | 4.82 |
Oprm1 |
opioid receptor, mu 1 |
4 |
0.99 |
chr8_94994139_94995207 | 4.82 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr17_48932346_48933546 | 4.82 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
567 |
0.85 |
chr6_93911862_93913573 | 4.81 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr1_66388178_66389004 | 4.76 |
Map2 |
microtubule-associated protein 2 |
1580 |
0.42 |
chr6_45059551_45060577 | 4.71 |
Cntnap2 |
contactin associated protein-like 2 |
3 |
0.98 |
chr6_18169814_18171281 | 4.64 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
140 |
0.95 |
chrX_133684344_133684778 | 4.50 |
Pcdh19 |
protocadherin 19 |
430 |
0.9 |
chr18_31445651_31446131 | 4.44 |
Syt4 |
synaptotagmin IV |
1515 |
0.34 |
chr1_158362036_158363261 | 4.41 |
Astn1 |
astrotactin 1 |
98 |
0.97 |
chr6_148046801_148048056 | 4.39 |
Far2 |
fatty acyl CoA reductase 2 |
12 |
0.57 |
chr3_34652462_34653573 | 4.38 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr8_94995811_94996872 | 4.35 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chrX_72656369_72656739 | 4.26 |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
294 |
0.9 |
chr18_35964551_35965976 | 4.23 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
158 |
0.94 |
chr18_31446492_31447667 | 4.22 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chrX_36195589_36196935 | 4.19 |
Zcchc12 |
zinc finger, CCHC domain containing 12 |
276 |
0.9 |
chr2_85197983_85199004 | 4.18 |
Lrrc55 |
leucine rich repeat containing 55 |
1296 |
0.28 |
chr3_108410436_108412210 | 4.16 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr7_40900813_40901175 | 4.15 |
A230077H06Rik |
RIKEN cDNA A230077H06 gene |
57 |
0.93 |
chr2_136713069_136714459 | 4.11 |
Snap25 |
synaptosomal-associated protein 25 |
286 |
0.92 |
chr19_6499251_6500132 | 4.10 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr2_180890379_180892235 | 4.09 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr1_42692676_42692896 | 4.09 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
307 |
0.82 |
chr3_88206822_88208169 | 4.04 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr9_52678302_52679671 | 3.99 |
AI593442 |
expressed sequence AI593442 |
443 |
0.69 |
chr1_99772154_99773556 | 3.98 |
Cntnap5b |
contactin associated protein-like 5B |
90 |
0.98 |
chr16_7039399_7040361 | 3.96 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
29966 |
0.27 |
chr10_127260074_127260771 | 3.93 |
Kif5a |
kinesin family member 5A |
2658 |
0.11 |
chr7_18925442_18925859 | 3.88 |
Nova2 |
NOVA alternative splicing regulator 2 |
238 |
0.86 |
chr3_8509825_8511666 | 3.86 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr10_87485570_87486803 | 3.85 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
7474 |
0.2 |
chr1_19213854_19215338 | 3.83 |
Tfap2b |
transcription factor AP-2 beta |
717 |
0.69 |
chr3_79144294_79146166 | 3.83 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr17_28145328_28147472 | 3.82 |
Scube3 |
signal peptide, CUB domain, EGF-like 3 |
3874 |
0.13 |
chr16_67618113_67618498 | 3.81 |
Cadm2 |
cell adhesion molecule 2 |
2188 |
0.39 |
chr3_94479508_94480443 | 3.79 |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
366 |
0.63 |
chr13_83721518_83722206 | 3.74 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
481 |
0.73 |
chr5_128952013_128953618 | 3.73 |
Rimbp2 |
RIMS binding protein 2 |
218 |
0.95 |
chr8_31089411_31091663 | 3.73 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chrX_166347339_166348040 | 3.71 |
Gpm6b |
glycoprotein m6b |
2847 |
0.32 |
chr17_93198991_93201483 | 3.68 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr3_27371157_27372632 | 3.67 |
Ghsr |
growth hormone secretagogue receptor |
543 |
0.81 |
chr8_96455054_96456367 | 3.66 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chr3_80800286_80803016 | 3.66 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chrX_79516609_79517863 | 3.65 |
Cfap47 |
cilia and flagella associated protein 47 |
49 |
0.99 |
chr9_91363965_91365514 | 3.65 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1029 |
0.35 |
chr7_44592789_44594513 | 3.64 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chr5_114090407_114091746 | 3.64 |
Svop |
SV2 related protein |
291 |
0.84 |
chrX_57503221_57504242 | 3.64 |
Gpr101 |
G protein-coupled receptor 101 |
26 |
0.98 |
chr13_54191853_54192989 | 3.60 |
Hrh2 |
histamine receptor H2 |
292 |
0.9 |
chr8_94869714_94871671 | 3.53 |
Dok4 |
docking protein 4 |
512 |
0.65 |
chr2_32741082_32742388 | 3.52 |
Sh2d3c |
SH2 domain containing 3C |
243 |
0.72 |
chr13_83724722_83725570 | 3.52 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2960 |
0.17 |
chr1_132541040_132543287 | 3.51 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr13_51417714_51418220 | 3.48 |
Gm32834 |
predicted gene, 32834 |
678 |
0.71 |
chr15_99527112_99528245 | 3.45 |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
3 |
0.96 |
chr11_57011376_57011642 | 3.44 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
122 |
0.98 |
chr6_127768524_127769705 | 3.44 |
Prmt8 |
protein arginine N-methyltransferase 8 |
358 |
0.74 |
chr18_42896024_42896175 | 3.44 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
2716 |
0.34 |
chr6_83185720_83187846 | 3.42 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr9_104569742_104570707 | 3.39 |
Cpne4 |
copine IV |
437 |
0.89 |
chr18_43686487_43688415 | 3.38 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr7_31049701_31050744 | 3.37 |
Fxyd7 |
FXYD domain-containing ion transport regulator 7 |
1181 |
0.24 |
chr2_70561988_70564432 | 3.36 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr7_16129541_16131199 | 3.36 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
22 |
0.96 |
chr3_88214322_88216234 | 3.36 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr17_35703094_35703425 | 3.35 |
Gm4577 |
predicted gene 4577 |
637 |
0.35 |
chr9_110054589_110054957 | 3.32 |
Map4 |
microtubule-associated protein 4 |
2721 |
0.19 |
chr2_152080491_152081480 | 3.29 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr14_64588312_64589438 | 3.28 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr7_44441951_44442938 | 3.27 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr7_43489310_43490670 | 3.26 |
Iglon5 |
IgLON family member 5 |
85 |
0.92 |
chr7_44336079_44337576 | 3.26 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr3_94478073_94479450 | 3.24 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr4_22487396_22488284 | 3.21 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
526 |
0.73 |
chr3_34638141_34639272 | 3.21 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
202 |
0.53 |
chr8_12400578_12402091 | 3.21 |
Gm25239 |
predicted gene, 25239 |
4931 |
0.15 |
chr7_6414737_6415889 | 3.21 |
Smim17 |
small integral membrane protein 17 |
138 |
0.89 |
chr5_121009225_121009749 | 3.18 |
Rph3a |
rabphilin 3A |
51 |
0.97 |
chr3_154663659_154664932 | 3.18 |
Erich3 |
glutamate rich 3 |
436 |
0.82 |
chr14_124191809_124193012 | 3.15 |
Fgf14 |
fibroblast growth factor 14 |
492 |
0.88 |
chr5_117414146_117414959 | 3.15 |
Ksr2 |
kinase suppressor of ras 2 |
552 |
0.7 |
chr17_28040550_28042470 | 3.13 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
227 |
0.89 |
chr7_79507205_79507895 | 3.13 |
Mir9-3 |
microRNA 9-3 |
2286 |
0.14 |
chr14_52009953_52011160 | 3.10 |
Zfp219 |
zinc finger protein 219 |
19 |
0.94 |
chr10_80300884_80302968 | 3.07 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr8_84770692_84772567 | 3.07 |
Nfix |
nuclear factor I/X |
1767 |
0.22 |
chr17_47484348_47484534 | 3.06 |
Taf8 |
TATA-box binding protein associated factor 8 |
17831 |
0.12 |
chr7_46396141_46398423 | 3.05 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
366 |
0.84 |
chr5_111422795_111423499 | 3.04 |
Gm43119 |
predicted gene 43119 |
442 |
0.8 |
chr5_125532320_125533519 | 3.03 |
Tmem132b |
transmembrane protein 132B |
532 |
0.76 |
chr15_72546044_72547992 | 3.03 |
Kcnk9 |
potassium channel, subfamily K, member 9 |
678 |
0.75 |
chr14_75455970_75456691 | 3.02 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
348 |
0.9 |
chr13_96130949_96131570 | 3.01 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1318 |
0.36 |
chr7_71960616_71961355 | 3.00 |
1700011C11Rik |
RIKEN cDNA 1700011C11 gene |
188 |
0.91 |
chr14_122480308_122481080 | 3.00 |
Zic2 |
zinc finger protein of the cerebellum 2 |
2594 |
0.16 |
chr4_97581535_97582274 | 2.99 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
2692 |
0.32 |
chr4_141052695_141054311 | 2.98 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
158 |
0.92 |
chr6_80019260_80020204 | 2.96 |
Lrrtm4 |
leucine rich repeat transmembrane neuronal 4 |
89 |
0.97 |
chr15_4375207_4376518 | 2.95 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
358 |
0.93 |
chr7_79505833_79506958 | 2.94 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr19_6418703_6419936 | 2.92 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr16_43506052_43507411 | 2.92 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1426 |
0.51 |
chr11_69835212_69835923 | 2.90 |
Nlgn2 |
neuroligin 2 |
718 |
0.33 |
chr3_55242295_55243824 | 2.88 |
Dclk1 |
doublecortin-like kinase 1 |
533 |
0.78 |
chr4_123526776_123528155 | 2.88 |
Macf1 |
microtubule-actin crosslinking factor 1 |
6 |
0.98 |
chr9_27791337_27792219 | 2.88 |
Opcml |
opioid binding protein/cell adhesion molecule-like |
476 |
0.89 |
chr4_127988222_127989180 | 2.86 |
Csmd2 |
CUB and Sushi multiple domains 2 |
657 |
0.77 |
chr9_41273163_41274326 | 2.84 |
Gm48710 |
predicted gene, 48710 |
44862 |
0.11 |
chr10_64087567_64088464 | 2.83 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
2232 |
0.46 |
chr18_59062200_59063436 | 2.83 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr14_64589664_64590503 | 2.83 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
388 |
0.55 |
chr2_163438209_163439457 | 2.83 |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
300 |
0.84 |
chr10_84756349_84757352 | 2.82 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
788 |
0.69 |
chr7_79503072_79503475 | 2.82 |
Mir9-3 |
microRNA 9-3 |
1991 |
0.16 |
chr17_47877478_47879368 | 2.80 |
Foxp4 |
forkhead box P4 |
530 |
0.7 |
chr13_83726534_83727321 | 2.80 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1179 |
0.35 |
chr10_33623738_33624906 | 2.79 |
Gm15939 |
predicted gene 15939 |
76 |
0.56 |
chr2_165367693_165368982 | 2.78 |
Zfp663 |
zinc finger protein 663 |
386 |
0.8 |
chr10_81472751_81473777 | 2.76 |
Celf5 |
CUGBP, Elav-like family member 5 |
114 |
0.9 |
chr16_9994378_9995594 | 2.76 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
63 |
0.98 |
chr7_44428985_44430475 | 2.76 |
Lrrc4b |
leucine rich repeat containing 4B |
712 |
0.43 |
chr4_139724528_139725287 | 2.75 |
Tas1r2 |
taste receptor, type 1, member 2 |
71358 |
0.08 |
chr3_73054296_73054541 | 2.75 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
2525 |
0.26 |
chr18_72348735_72348916 | 2.75 |
Dcc |
deleted in colorectal carcinoma |
2192 |
0.45 |
chr4_57637702_57639097 | 2.74 |
Pakap |
paralemmin A kinase anchor protein |
424 |
0.89 |
chr10_109010138_109010322 | 2.74 |
Syt1 |
synaptotagmin I |
732 |
0.77 |
chr14_52310870_52313267 | 2.74 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr15_82924366_82924785 | 2.73 |
Tcf20 |
transcription factor 20 |
12441 |
0.14 |
chr4_25799045_25800424 | 2.72 |
Fut9 |
fucosyltransferase 9 |
121 |
0.96 |
chr15_78119178_78120215 | 2.72 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
10 |
0.83 |
chr7_19177965_19179153 | 2.71 |
Eml2 |
echinoderm microtubule associated protein like 2 |
2138 |
0.13 |
chrX_110812404_110812672 | 2.71 |
Gm44593 |
predicted gene 44593 |
214 |
0.93 |
chr16_65105187_65106202 | 2.71 |
Htr1f |
5-hydroxytryptamine (serotonin) receptor 1F |
160 |
0.97 |
chr7_30291688_30292446 | 2.69 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
109 |
0.9 |
chr8_70317565_70317878 | 2.68 |
Cers1 |
ceramide synthase 1 |
629 |
0.54 |
chr14_124675118_124677112 | 2.67 |
Fgf14 |
fibroblast growth factor 14 |
1012 |
0.63 |
chr2_181155937_181157234 | 2.67 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr18_77560987_77561705 | 2.64 |
Rnf165 |
ring finger protein 165 |
3263 |
0.29 |
chr9_40344899_40346384 | 2.63 |
Gramd1b |
GRAM domain containing 1B |
649 |
0.55 |
chr12_75176309_75177605 | 2.62 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr6_136171767_136172200 | 2.59 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
94 |
0.95 |
chr17_48934259_48934883 | 2.57 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
2192 |
0.43 |
chr11_42419852_42421693 | 2.56 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
507 |
0.88 |
chr2_181767278_181768191 | 2.56 |
Myt1 |
myelin transcription factor 1 |
222 |
0.91 |
chr11_97570938_97571787 | 2.55 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
2567 |
0.19 |
chr1_92849002_92850443 | 2.55 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr1_77512287_77513134 | 2.54 |
Epha4 |
Eph receptor A4 |
2369 |
0.26 |
chr19_55897010_55897961 | 2.54 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
824 |
0.72 |
chr13_42709652_42710400 | 2.54 |
Phactr1 |
phosphatase and actin regulator 1 |
445 |
0.88 |
chr4_117373485_117374541 | 2.53 |
Rnf220 |
ring finger protein 220 |
1444 |
0.39 |
chr16_43504197_43504424 | 2.53 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
613 |
0.8 |
chr6_124863054_124863787 | 2.53 |
Gpr162 |
G protein-coupled receptor 162 |
292 |
0.76 |
chrX_12074270_12074421 | 2.53 |
Bcor |
BCL6 interacting corepressor |
6208 |
0.28 |
chr5_111958129_111958658 | 2.52 |
Gm42488 |
predicted gene 42488 |
14158 |
0.25 |
chrX_140341868_140343066 | 2.52 |
Frmpd3 |
FERM and PDZ domain containing 3 |
204 |
0.95 |
chrX_72655248_72656218 | 2.52 |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
453 |
0.82 |
chr2_75054647_75055442 | 2.51 |
Gm13652 |
predicted gene 13652 |
82754 |
0.07 |
chr13_68597214_68598387 | 2.51 |
1700001L19Rik |
RIKEN cDNA 1700001L19 gene |
361 |
0.83 |
chrX_66649259_66650015 | 2.51 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
319 |
0.89 |
chr8_9770297_9772011 | 2.51 |
Fam155a |
family with sequence similarity 155, member A |
7 |
0.79 |
chr16_77537075_77537402 | 2.49 |
Gm36963 |
predicted gene, 36963 |
2644 |
0.18 |
chr5_131531462_131532675 | 2.49 |
Auts2 |
autism susceptibility candidate 2 |
2329 |
0.29 |
chr8_125897573_125897839 | 2.49 |
A730098A19Rik |
RIKEN cDNA A730098A19 gene |
208 |
0.8 |
chr11_120238467_120239478 | 2.48 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
2273 |
0.16 |
chr7_131968073_131968591 | 2.48 |
Gpr26 |
G protein-coupled receptor 26 |
1872 |
0.37 |
chr6_134886811_134888239 | 2.48 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr6_121472749_121474141 | 2.47 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
178 |
0.95 |
chr15_86875042_86876223 | 2.46 |
Gm49466 |
predicted gene, 49466 |
48450 |
0.14 |
chr18_79105943_79106581 | 2.46 |
Setbp1 |
SET binding protein 1 |
3129 |
0.37 |
chr15_83723881_83724305 | 2.45 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
833 |
0.67 |
chr17_17828911_17829692 | 2.45 |
Mir99b |
microRNA 99b |
887 |
0.24 |
chr4_140245362_140247262 | 2.45 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr11_117491673_117492107 | 2.45 |
Gm11733 |
predicted gene 11733 |
7522 |
0.15 |
chr19_8664063_8664996 | 2.45 |
Chrm1 |
cholinergic receptor, muscarinic 1, CNS |
524 |
0.51 |
chr9_40685768_40687221 | 2.44 |
Clmp |
CXADR-like membrane protein |
459 |
0.69 |
chrX_135210129_135210918 | 2.43 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
164 |
0.93 |
chr5_65130636_65132102 | 2.43 |
Klhl5 |
kelch-like 5 |
34 |
0.97 |
chr7_78578212_78578444 | 2.43 |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
75 |
0.88 |
chr10_92162169_92163486 | 2.42 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
66 |
0.98 |
chr9_107706739_107707764 | 2.42 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
1695 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.4 | 13.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.8 | 8.5 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
2.7 | 8.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
2.7 | 8.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.6 | 23.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.2 | 6.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
2.1 | 6.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.1 | 6.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.1 | 6.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.0 | 11.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.8 | 5.4 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.6 | 4.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.6 | 15.5 | GO:0071625 | vocalization behavior(GO:0071625) |
1.5 | 7.6 | GO:0072017 | distal tubule development(GO:0072017) |
1.5 | 1.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.5 | 4.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.5 | 4.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.5 | 2.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.4 | 2.9 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.3 | 4.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.3 | 3.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.3 | 2.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.3 | 3.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.3 | 5.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 3.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.2 | 3.7 | GO:0033058 | directional locomotion(GO:0033058) |
1.2 | 4.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.2 | 10.8 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
1.2 | 3.6 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.2 | 4.8 | GO:0007412 | axon target recognition(GO:0007412) |
1.2 | 3.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 1.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.2 | 3.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.2 | 4.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.1 | 3.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.1 | 5.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 5.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.1 | 3.4 | GO:0048880 | sensory system development(GO:0048880) |
1.1 | 9.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.1 | 8.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.1 | 4.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.1 | 1.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.1 | 3.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.1 | 3.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.1 | 5.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.0 | 3.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.0 | 7.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.0 | 9.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.0 | 5.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.0 | 3.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.0 | 3.1 | GO:0060594 | mammary gland specification(GO:0060594) |
1.0 | 4.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 6.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.0 | 2.0 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 4.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 1.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.0 | 1.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 2.9 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.9 | 3.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.9 | 13.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 1.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 3.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.9 | 3.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 22.9 | GO:0007616 | long-term memory(GO:0007616) |
0.9 | 0.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 4.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 2.6 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.9 | 2.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 2.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.9 | 1.7 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.9 | 2.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.8 | 2.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.8 | 2.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 | 4.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 18.5 | GO:0001964 | startle response(GO:0001964) |
0.8 | 3.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.8 | 3.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.8 | 2.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 2.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.8 | 1.6 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.8 | 2.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.8 | 2.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.8 | 3.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.8 | 5.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.8 | 2.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.8 | 9.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.8 | 2.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.8 | 2.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 3.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 39.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 1.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 3.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.7 | 1.4 | GO:0046959 | habituation(GO:0046959) |
0.7 | 2.8 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.7 | 2.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 2.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 2.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.7 | 7.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.7 | 1.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.7 | 0.7 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.7 | 2.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.7 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.7 | 1.3 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.7 | 0.7 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.7 | 4.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.7 | 3.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 3.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 7.0 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.6 | 1.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 1.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.6 | 14.9 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.6 | 1.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 2.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 10.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 3.6 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.6 | 3.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.6 | 1.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.6 | 4.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 | 2.3 | GO:0090427 | activation of meiosis(GO:0090427) |
0.6 | 0.6 | GO:0097491 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) facioacoustic ganglion development(GO:1903375) |
0.6 | 1.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.6 | 1.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.6 | 2.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 1.7 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.6 | 1.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.6 | 1.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 2.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.5 | 5.5 | GO:0060384 | innervation(GO:0060384) |
0.5 | 1.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.5 | 0.5 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 4.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 0.5 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.5 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 0.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 2.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 2.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 1.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.5 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.5 | 2.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.5 | 1.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 1.0 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 1.5 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 7.3 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 0.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 5.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.5 | 2.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 0.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.5 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.5 | 3.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 0.9 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.5 | 14.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 1.8 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 1.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 1.8 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 0.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.4 | 1.8 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.4 | 32.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 6.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 1.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 0.9 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.4 | 1.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 0.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.4 | 1.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 0.9 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.4 | 5.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 0.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 0.4 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.4 | 1.2 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 1.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.8 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 2.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.4 | 6.8 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.4 | 0.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 0.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.4 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 0.8 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.4 | 8.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 9.7 | GO:0021766 | hippocampus development(GO:0021766) |
0.4 | 2.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.4 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 2.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.4 | 0.7 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.4 | 4.8 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 0.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 1.1 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 1.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.4 | 2.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 6.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 2.2 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 1.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 0.7 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 0.7 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 0.7 | GO:0099612 | protein localization to axon(GO:0099612) |
0.4 | 1.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 2.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 2.1 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 1.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 0.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.7 | GO:0001975 | response to amphetamine(GO:0001975) |
0.3 | 2.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.3 | 1.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.3 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.3 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 1.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 1.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 3.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.3 | 1.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 17.3 | GO:0007612 | learning(GO:0007612) |
0.3 | 3.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 0.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 0.3 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 1.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 9.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 0.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.3 | 4.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.3 | 0.9 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.6 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 2.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.3 | 0.9 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 1.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 0.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.6 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.3 | 1.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 0.9 | GO:0014047 | glutamate secretion(GO:0014047) |
0.3 | 0.6 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 0.3 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.3 | 15.4 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 0.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 0.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 0.3 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.3 | 0.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 1.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 2.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.3 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.3 | 0.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 6.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 0.8 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 1.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.3 | 3.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 1.3 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.3 | 0.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 1.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.3 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.3 | 0.8 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 0.5 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 2.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 1.7 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 1.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 1.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.5 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.5 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.2 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.4 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 2.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 1.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 4.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.7 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 0.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 2.4 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 1.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 4.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 1.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 1.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 2.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 13.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.2 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.2 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.4 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.6 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 3.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 0.6 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 5.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 1.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 8.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.4 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 2.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 1.6 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.7 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.2 | 0.2 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.2 | 2.5 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.6 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.2 | 0.2 | GO:1902688 | regulation of fermentation(GO:0043465) response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.2 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.7 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.2 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.3 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.2 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 1.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.3 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.7 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.6 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.7 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.9 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 2.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.4 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 1.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 1.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.4 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 1.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.1 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 1.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 1.5 | GO:0032401 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.2 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.1 | 0.2 | GO:1902475 | L-glutamate transmembrane transport(GO:0089711) L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.7 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.5 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.7 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.3 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.1 | 0.1 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.2 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 2.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.9 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.2 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 11.0 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 0.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.5 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 3.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.7 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.7 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 4.0 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 1.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.4 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.5 | GO:0015844 | monoamine transport(GO:0015844) |
0.0 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 1.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.0 | 0.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.0 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.0 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) intermembrane transport(GO:0046909) |
0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.0 | 0.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.0 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.0 | 0.0 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.5 | GO:0044308 | axonal spine(GO:0044308) |
2.2 | 6.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.8 | 5.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.8 | 10.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 15.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.5 | 5.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.5 | 17.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.4 | 1.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.3 | 6.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.3 | 2.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.2 | 3.6 | GO:0072534 | perineuronal net(GO:0072534) |
1.2 | 13.0 | GO:0043194 | axon initial segment(GO:0043194) |
1.1 | 1.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.0 | 27.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 1.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 18.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.0 | 2.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 5.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 0.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.9 | 39.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 5.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 6.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 11.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.7 | 7.2 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 7.0 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 6.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 17.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 18.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 4.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 1.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 5.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 8.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 1.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 1.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 18.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 2.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 4.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 4.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 23.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 9.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 0.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 2.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.4 | 0.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 51.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 3.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 3.0 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 1.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 2.9 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 26.0 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 1.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 3.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 2.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.0 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 4.0 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 1.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 2.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 9.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 1.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 3.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 14.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 9.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 14.4 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 4.7 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 0.5 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 25.8 | GO:0045202 | synapse(GO:0045202) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 2.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.3 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 2.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 14.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 6.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 6.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 1.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 5.3 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 8.1 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 4.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 16.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.9 | 8.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.6 | 5.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.4 | 7.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.7 | 6.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.5 | 7.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 7.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.4 | 4.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.3 | 4.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.2 | 10.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.2 | 3.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 5.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 7.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 4.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 4.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.0 | 3.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.0 | 8.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 3.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.0 | 7.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 2.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 18.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.9 | 2.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 1.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.9 | 2.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 1.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 4.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 4.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.9 | 2.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.9 | 2.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.8 | 4.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.8 | 8.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 2.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 5.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.8 | 3.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 3.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 2.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 2.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 2.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.7 | 13.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 3.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.6 | 9.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 2.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.6 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 1.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 6.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 2.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.6 | 4.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 2.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.6 | 2.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 4.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.6 | 3.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 3.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 2.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 4.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 5.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.5 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 2.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 2.1 | GO:0099528 | G-protein coupled acetylcholine receptor activity(GO:0016907) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.5 | 10.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 2.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 14.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 3.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.5 | 2.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 2.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 2.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 2.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 15.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 1.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 0.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.5 | 4.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.5 | 2.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 5.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 5.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 4.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 1.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 2.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 5.0 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 12.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.5 | GO:0033265 | choline binding(GO:0033265) |
0.4 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 2.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 0.4 | GO:1901338 | catecholamine binding(GO:1901338) |
0.4 | 10.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 7.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 9.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 5.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 7.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 1.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 8.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 6.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 5.8 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 3.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 2.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 2.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 2.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 3.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 1.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.9 | GO:0018568 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 1.2 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.3 | 1.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 4.6 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 0.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 5.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 2.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 3.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 1.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 3.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.7 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 0.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 4.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 2.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 3.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 2.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 2.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 2.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 2.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 3.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 8.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 4.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.2 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 1.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 2.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 2.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 7.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 5.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.2 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.2 | 0.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 1.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 3.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 1.8 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 10.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 7.4 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 3.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 2.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 4.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 3.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 3.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 1.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 2.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.4 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 2.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 3.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 9.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.4 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.7 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 3.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0034785 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 1.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 23.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 4.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 1.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0034859 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 10.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 2.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0046428 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 15.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 6.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 11.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 10.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 7.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 3.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 11.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 9.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 6.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 4.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 1.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 4.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 3.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 7.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 18.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 4.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 7.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 32.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.4 | 16.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.3 | 14.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.0 | 10.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 3.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.8 | 11.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 9.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 1.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.6 | 5.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 23.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 5.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 5.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.5 | 11.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 0.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 5.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 8.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 11.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 9.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 3.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 3.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 0.8 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.4 | 4.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 2.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 4.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 3.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 1.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 7.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 3.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 4.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 4.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.3 | 2.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 3.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 5.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 9.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 3.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 4.6 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 3.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 12.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 4.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 1.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 3.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 4.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 18.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.0 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 1.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |